Targeting Trimethylamine N-Oxide: A New Therapeutic Strategy for Alleviating Atherosclerosis

Atherosclerosis (AS) is one of the most common cardiovascular diseases (CVDs), and there is currently no effective drug to reverse its pathogenesis. Trimethylamine N-oxide (TMAO) is a metabolite of the gut flora with the potential to act as a new risk factor for CVD. Many studies have shown that TMA...

Descripción completa

Detalles Bibliográficos
Autores principales: Jing, Lele, Zhang, Honghong, Xiang, Qiannan, Shen, Liang, Guo, Xiaoxia, Zhai, Changlin, Hu, Huilin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235870/
https://www.ncbi.nlm.nih.gov/pubmed/35770223
http://dx.doi.org/10.3389/fcvm.2022.864600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235870/
https://www.ncbi.nlm.nih.gov/pubmed/35770223
http://dx.doi.org/10.3389/fcvm.2022.864600

Ejemplares similares